These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3281171)

  • 21. Determination of the number of lytic sites in biconcave and spheroid erythrocyte ghosts after complement lysis.
    Bauer J; Podack ER; Valet G
    J Immunol; 1979 May; 122(5):2032-6. PubMed ID: 448115
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interaction between the complement and the coagulation systems].
    Arroyave CM
    Bol Med Hosp Infant Mex; 1975; 32(2):297-305. PubMed ID: 1138710
    [No Abstract]   [Full Text] [Related]  

  • 24. Binding of desoxycholate, phosphatidylcholine vesicles, lipoprotein and of the S-protein to complexes of terminal complement components.
    Podack ER; Müller-Eberhard HJ
    J Immunol; 1978 Sep; 121(3):1025-30. PubMed ID: 690431
    [No Abstract]   [Full Text] [Related]  

  • 25. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 26. [Complement activation and biological activities].
    Inoue K
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract]   [Full Text] [Related]  

  • 27. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
    Kitamura H; Tsuboi M; Nagaki K
    Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL; Berger M; Hammer CH; Meltzer MS
    J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of C6, C7, C9 and C1-INH analysis].
    Akagaki Y; Inai S
    Nihon Rinsho; 1990 Feb; 48 Suppl():662-5. PubMed ID: 2113138
    [No Abstract]   [Full Text] [Related]  

  • 30. Membrane attack by complement.
    Podack ER; Tschopp J
    Mol Immunol; 1984 Jul; 21(7):589-603. PubMed ID: 6379417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional properties of the asialo-fifth component of human complement.
    Schultz DR; Arnold PI
    J Immunol; 1990 Jul; 145(2):655-61. PubMed ID: 2114446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lipoproteins and C567-INH activity.
    Lint TF; Behrends CL; Gewurz H
    J Immunol; 1977 Sep; 119(3):883-8. PubMed ID: 561124
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction.
    Sundsmo JS; Fair DS
    Clin Physiol Biochem; 1983; 1(2-5):225-84. PubMed ID: 6241121
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunologic tests: C6, C7, C8 and C9].
    Hatanaka M; Shimizu A
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():92-4. PubMed ID: 16111197
    [No Abstract]   [Full Text] [Related]  

  • 35. Size of the transmembrane channels produced by complement proteins C5b-8.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1982 Sep; 129(3):1143-6. PubMed ID: 6286757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.
    Ballow M; Fang F; Good RA; Day NK
    Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reaction of partial identity between the C56-9 complex derived from target membranes and from inulin-activated serum.
    Bhakdi S; Bhakdi-Lehnen B; Ey P; Bjerrum OJ
    Monogr Allergy; 1977; 12():56-61. PubMed ID: 411027
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
    Nemerow GR; Yamamoto KI; Lint TF
    J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
    [No Abstract]   [Full Text] [Related]  

  • 40. Deviated lysis: Transfer of complement lytic activity to unsensitized cells II. Generation of the activity by inulin and by antigen antibody complexes.
    Rother U; Hänsch G; Rother K
    Z Immunitatsforsch Immunobiol; 1976 Aug; 151(1):442-54. PubMed ID: 785847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.